CJC-1295 in Ken Caryl — GHRH Analog Research Guide
CJC-1295 research guide for Ken Caryl. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
CJC-1295 isn't available on pharmacy shelves in Ken Caryl or virtually any local market — it's a research compound available through a dedicated online market. What this means for Ken Caryl researchers is that your location matters far less than your ability to evaluate vendor quality — and those evaluation tools are available to every researcher. What consistently distinguishes top CJC-1295 vendors is complete batch-specific analytical documentation: HPLC for purity, mass spec for peptide identity confirmation, and endotoxin testing for safety documentation. This guide takes Ken Caryl researchers through that evaluation process and explains how to verify CJC-1295 vendor quality step by step.
Understanding CJC-1295 — Biology & Evidence
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Ken Caryl comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
How to Source CJC-1295 — Vendor Guide
Quality CJC-1295 sourcing begins with a useful first test: does this vendor make batch-matched COAs available before purchase? Vendors who do are demonstrating research-grade standards. The HPLC purity trace is the most important document in the COA: it should show a large primary peak representing CJC-1295, with negligible secondary peaks representing impurities — purity should be at or above 98%. Red flags in CJC-1295 vendor evaluation: prices more than 30-40% below standard market rates, unclear production details, no community presence, and COAs that omit endotoxin testing. Bacteriostatic water is the appropriate reconstitution medium for CJC-1295 — it contains 0.9% benzyl alcohol that inhibits bacterial growth and extends reconstituted shelf life to 4 weeks when kept refrigerated.
Order CJC-1295 — ships to Ken Caryl
COA-verified · International tracking · Research grade
All use of CJC-1295 in Ken Caryl or anywhere constitutes research use — this compound is not approved for clinical human use, and all handling should adhere to research compound handling standards. Proper handling of CJC-1295 requires sterile reconstitution technique — swabbed septum with alcohol prep pad, new needle for each draw, clean preparation area — and cold chain maintenance from receipt through use. Verify the endotoxin level in your CJC-1295 batch COA before any injectable research application — look for results reported in endotoxin units per mg or mL and confirm they fall within appropriate thresholds. Protocol documentation — recording exactly what was used, when, and how — is a fundamental research principle that allows any unexpected observations to be properly contextualised.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
